Vaccines

ACIP delayed a vote on lifting a federal pause on the single-dose COVID-19 vaccine.

U.S. regulators is taking a pause on administering the vaccine while experts study a small number of blood clots.

Travel restrictions have been loosened for those who’ve been vaccinated against COVID-19.

The move clarifies the number of doses that can be administered from each vial and approves larger vials.

Data from the Coronavirus Resource Center at Johns Hopkins University and the Centers for Disease Control.

AMA President Susan R. Bailey, MD, says it is time for physicians to take a more commanding position in the vaccination effort.

An analysis by the drug maker shows the vaccine may be more effective in adolescent patients than in adults.

Agencies will provide about $100 million in grants to aging and disability networks across the country.

The updated data was released after U.S. regulators questioned a release earlier this week.

An online survey conducted in late-2020 shows what drove vaccine hesitancy.

The vaccine candidate met the primary efficacy endpoint in preventing COVID-19 in an interim analysis.

The national average payment rate will increase by about $12 for administering each dose of the vaccines.

A look at data from the swine flu pandemic shows that physicians who talk vaccination with their doctor often get the shot.

President Joe R. Biden marked the anniversary of the onset of the COVID-19 coronavirus pandemic with a flood of action.

The new doses will spring from the production partnership of Johnson & Johnson and Merck.

Those who have been fully vaccinated can safely visit other vaccinated people and small groups of those who have yet to get the jab.

The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.

Multiple news organizations report that the White House has brokered the unusual deal.

The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.

The single-dose vaccine is the third granted emergency use authorization in an effort to end the COVID-19 coronavirus pandemic.

Documents released by the FDA before they consider an EUA for the single-dose vaccine show that it is effective against COVID-19.

The drug maker expects to deliver 120 million doses of its COVID-19 vaccine by the end of March.

The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar tomorrow at 6 p.m. EST.

More than half of Americans expect disruptions to persist past the middle of this year, a jump from late-December’s responses.

The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar at 6 p.m. EST, Feb. 24.

In a pair of letters to congressional committees, the organization extolls the benefits of provisions in upcoming COVID relief legislation.

Primary care physicians are getting involved with the vaccination effort, but only 19 percent say they’re currently administering the shots.

The public service announcement urges Americans to be vaccinated against COVID-19.

The drug maker has started reviews with regulatory agencies across the world.

The company plans to supply the federal government with 100 million doses in the first half of 2021.